Its simply the advancement of sigma 1 research and understanding that is growing by leaps and bounds.
next 1-6 months are of enormous importance to the company and shareholders - need good AZ data, filing to EMA and start new trials. 1. I could never understand the failure of management to push forward Parkinson after phase 2 results were so good. Its been 2+ years? 2. I could never understand the failure to follow up on RETT - its been 6 months
I have read the board and nobody seems to have a reasonable explanation. I also have used the ignore a lot....I hope that the chairman would hold the ceo accountable at some point if not today. For all those PHD have failed to design a robust trial in RETT....shame on them. Calling IR or their external arm - its hopeless to get any information or to pass it to management. So I wait a little more....my patience is on its last 6 months.